MetaCap

SIGA Technologies (SIGA) vs Vogenx (VOGX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Vogenx is the larger company by market cap ($259.8 million vs $235.7 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SIGA+14.29%VOGX+34.54%
+171%+81%-8%
Aug 12, 20261 yearOct 8, 2026
SIGA+9.33%VOGX+18.34%
+136%+65%-6%
Aug 10, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SIGA versus VOGX key metrics
MetricSIGAVOGX
Share price$3.28$17.49
Market cap$235.67M$259.82M
1-day change+0.61%+8.23%
YTD return-46.32%—
1-year return-60.39%—
5-year return-53.87%—
Forward P/E3.04—
EPS (TTM)$-0.04$-0.22
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$8.55$38.41
52-week low$2.83$12.95
Distance from 52-week high-61.64%-54.46%
Analyst consensusnonestrong_buy
Avg. price target upside—+214.47%
Average volume726.50K188.79K
Shares outstanding71.85M14.86M
Employees494
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About SIGA Technologies

SIGA stock →

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.

Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees

About Vogenx

VOGX stock →

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

SIGA vs VOGX FAQ

Which is bigger, SIGA Technologies or Vogenx?

Vogenx (VOGX) is larger, with a market capitalization of $259.82M compared with $235.67M for SIGA Technologies (SIGA).

Are SIGA Technologies and Vogenx in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons